administered treatment for Hepatitis C, developed by Philippe Halfon, co-founder and President of Genoscience. BL-8030 – second-generation NS3 protease inhibitor for oral treatment of Hepatitis C, invented by Philippe Halfon See also TA BlueTech Index List of Israeli companies quoted on the Nasdaq References External links BioJerusalem Jerusalem Development Authority Office of the Chief Scientist of Israel Companies listed on the Tel Aviv Stock Exchange Biotechnology companies established in 2003 Biotechnology companies of Israel Companies listed on the Nasdaq Drug discovery companies 2003 establishments in Israel